Analyze Diet
Frontiers in veterinary science2017; 4; 152; doi: 10.3389/fvets.2017.00152

Comparison of the Effects of Interleukin-1 on Equine Articular Cartilage Explants and Cocultures of Osteochondral and Synovial Explants.

Abstract: Osteoarthritis (OA) is a ubiquitous disease affecting many horses. The disease causes chronic pain and decreased performance for patients and great cost to owners for diagnosis and treatment. The most common treatments include systemic non-steroidal anti-inflammatory drugs and intra-articular injection of corticosteroids. There is excellent support for the palliative pain relief these treatments provide; however, they do not arrest progression and may in some instances hasten advancement of disease. Orthobiologic treatments have been investigated as potential OA treatments that may not only ameliorate pain but also prevent or reverse pathologic articular tissue changes. Clinical protocols for intra-articular use of such treatments have not been optimized; the high cost of in vivo research and concerns over humane use of research animals may be preventing discovery. The objective of this study was to evaluate a novel in vitro articular coculture system for future use in OA treatment research. Concentrations and fold increases in various markers of inflammation (prostaglandin E2 and tumor necrosis factor-alpha), degradative enzyme activity [matrix metalloproteinase-13 (MMP-13)], cartilage and bone metabolism (bone alkaline phosphatase and dimethyl-methylene blue), and cell death (lactate dehydrogenase) were compared between IL-1-stimulated equine articular cartilage explant cultures and cocultures comprised of osteochondral and synovial explants (OCS). Results suggested that there are differences in responses of culture systems to inflammatory stimulation. In particular, the IL-1-induced fold changes in MMP-13 concentration were significantly different between OCS and cartilage explant culture systems after 96 h. These differences may be relevant to responses of joints to inflammation in vivo and could be important to the biological relevance of in vitro research findings.
Publication Date: 2017-09-20 PubMed ID: 28979900PubMed Central: PMC5611359DOI: 10.3389/fvets.2017.00152Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article presents a study comparing the effects of Interleukin-1 on equine articular cartilage and a coculture system comprised of osteochondral and synovial explants. The objective was to evaluate a new method for osteoarthritis treatment research.

Introduction and Background

  • Osteoarthritis (OA) is a common disease in horses, causing chronic pain, decrease in performance, and high costs associated with diagnosis and treatment.
  • Conventional treatments like non-steroidal anti-inflammatory drugs and corticosteroids injections provide temporary relief but do not halt the progression of the disease, and sometimes may even accelerate it.
  • The study therefore investigates orthobiologic treatments that can potentially not only relieve pain but also reverse or prevent pathologic tissue changes.
  • Clinical protocols for such treatments are yet to be optimized due to the high cost of research and concerns over the humane use of research animals.

Methodology

  • The research introduces a novel articular coculture system as a potential tool for OA treatment research.
  • The system was tested using inflamation markers (prostaglandin E, tumor necrosis factor-alpha), a degradative enzyme (matrix metalloproteinase-13 or MMP-13), indicators of cartilage and bone metabolism (bone alkaline phosphatase and dimethyl-methylene blue), and a marker of cell death (lactate dehydrogenase) across two different culture systems.
  • The two systems compared were the IL-1-stimulated equine articular cartilage explant cultures and cocultures comprised of osteochondral and synovial explants.

Findings

  • The outcome suggested differences in the way the two culture systems responded to inflammatory stimulation.
  • Specifically, the changes in MMP-13 concentration, which was induced by IL-1, were considerably different between the two systems after 96 hours.
  • The distinction in these responses may have implications for the way joints respond to inflammation, making these findings potentially vital to the relevance of research in this area.

Cite This Article

APA
Byron CR, Trahan RA. (2017). Comparison of the Effects of Interleukin-1 on Equine Articular Cartilage Explants and Cocultures of Osteochondral and Synovial Explants. Front Vet Sci, 4, 152. https://doi.org/10.3389/fvets.2017.00152

Publication

ISSN: 2297-1769
NlmUniqueID: 101666658
Country: Switzerland
Language: English
Volume: 4
Pages: 152

Researcher Affiliations

Byron, Christopher R
  • Department of Large Animal Clinical Sciences, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA, Unites States.
Trahan, Richard A
  • Department of Large Animal Clinical Sciences, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA, Unites States.

References

This article includes 38 references
  1. Dabareiner RM, Cohen ND, Carter GK, Nunn S, Moyer W. Lameness and poor performance in horses used for team roping: 118 cases (2000-2003).. J Am Vet Med Assoc (2005) 226:1694–9.
    doi: 10.2460/javma.2005.226.1694pubmed: 15906571google scholar: lookup
  2. Rossdale PD, Hopes R, Digby NJ, offord K. Epidemiological study of wastage among racehorses, 1982 and 1983.. Vet Rec (1985) 116:66–9.
    doi: 10.1136/vr.116.3.66pubmed: 3976145google scholar: lookup
  3. Frisbie DD, Kawcak CE, Baxter GM, Trotter GW, Powers BE, Lasson ED. Effects of 6α-methylprednisolone acetate on an equine osteochondral fragment exercise model.. Am J Vet Res (1998) 59:1619–28.
    pubmed: 9858417
  4. Broeckx S, Zimmerman M, Crocetti S, Suls M, Mariën T, Ferguson SJ. Regenerative therapies for equine degenerative joint disease: a preliminary study.. PLoS One (2014) 9:e85917.
  5. Frisbie DD, Kawcak CE, Werpy NM, Park RD, McIlwraith CW. Clinical, biochemical, and histologic effects of intra-articular administration of autologous conditioned serum in horses with experimentally induced osteoarthritis.. Am J Vet Res (2007) 68:290–6.
    doi: 10.2460/ajvr.68.3.290pubmed: 17331019google scholar: lookup
  6. Fortier LA, Travis AJ. Stem cells in veterinary medicine.. Stem Cell Res Ther (2011) 2:9.
    doi: 10.1186/scrt50pmc: PMC3092149pubmed: 21371354google scholar: lookup
  7. Carlson ER, Stewart AA, Carlson KL, Durgam SS, Pondenis HC. Effects of serum and autologous conditioned serum on equine articular chondrocytes treated with interleukin-1β.. Am J Vet Res (2013) 74:700–5.
    doi: 10.2460/ajvr.74.5.700pubmed: 23627382google scholar: lookup
  8. Block JA, Oegema TR, Sandy JD, Plaas A. The effects of oral glucosamine on joint health: is a change in research approach needed?. Osteoarthritis Cartilage (2010) 18:5–11.
    doi: 10.1016/j.joca.2009.07.005pubmed: 19733270google scholar: lookup
  9. Kumarasinghe DD, Hopwood B, Kuliwaba JS, Atkins GJ, Fazzalari NL. An update on primary hip osteoarthritis including altered Wnt and TGF-b associated gene expression from the bony component of the disease.. Rheumatology (2011) 50:2166–75.
    doi: 10.1093/rheumatology/ker291pubmed: 21984764google scholar: lookup
  10. Theiler R, Ghosh P, Brooks P. Clinical, biochemical and imaging methods of assessing osteoarthritis and clinical trials with agents claiming chondromodulating activity.. Osteoarthritis Cartilage (1994) 2:1–23.
    doi: 10.1016/S1063-4584(05)80002-0pubmed: 11548220google scholar: lookup
  11. Gregg AJ, Fortier LA, Mohammed HO, Mayr KG, Miller BJ, Haupt JL. Assessment of the catabolic effects of interleukin-1β on proteoglycan metabolism in equine cartilage cocultured with synoviocytes.. Am J Vet Res (2006) 67:957–62.
    doi: 10.2460/ajvr.67.6.957pubmed: 16740087google scholar: lookup
  12. Amin AK, Huntley JS, Simpson AHRW, Hall AC. Chondrocyte survival in articular cartilage: the influence of subchondral bone in a bovine model.. J Bone Joint Surg (2009) 91-B:691–9.
    doi: 10.1302/0301-620X.91B5.21544pubmed: 19407309google scholar: lookup
  13. Cook JL, Kuroki K, Stoker A, Streppa H, Fox DB. Review of in vitro models and development and initial validation of a novel co-culture model for the study of osteoarthritis.. Curr Rheumatol Rev (2007) 3:172–82.
  14. Anz A, Smith MJ, Stoker A, Linville C, Markway H, Branson K. The effect of bupivacaine and morphine in a coculture model of diarthrodial joints.. Arthroscopy (2009) 25:225–31.
    doi: 10.1016/j.arthro.2008.12.003pubmed: 19245983google scholar: lookup
  15. Lee JH, Fitzgerald JB, DiMicco MA, Cheng DM, Flannery CR, Sandy JD. Co-culture of mechanically injured cartilage with joint capsule tissue alters chondrocyte expression patterns and increases ADAMTS5 production.. Arch Biochem Biophys (2009) 489:118–26.
    doi: 10.1016/j.abb.2009.07.006pmc: PMC2752630pubmed: 19607802google scholar: lookup
  16. Beekhuizen M, Bastiaansen-Jenniskens YM, Koevoet W, Saris DB, Dhert WJ, Creemers LB. Osteoarthritic synovial tissue inhibition of proteoglycan production in human osteoarthritic knee cartilage: establishment and characterization of a long-term cartilage-synovium coculture.. Arthritis Rheum (2011) 63:1918–27.
    doi: 10.1002/art.30364pubmed: 21437876google scholar: lookup
  17. Pool RR. Pathologic manifestations of joint disease in the athletic horse.. In: McIlwraith CW, Trotter GW, editors. Joint Disease in the Horse. Philadelphia: WB Saunders Co; (1996). p. 87–104..
  18. Hewitt KM, Stringer MD. Correlation between the surface area of synovial membrane and the surface area of articular cartilage in synovial joints of the mouse and human.. Surg Radiol Anat (2008) 30:645–51.
    doi: 10.1007/s00276-008-0399-1pubmed: 18679561google scholar: lookup
  19. Byron CR, Barger AM, Stewart AA, Pondenis HC, Fan TM. In vitro expression of receptor activator of nuclear factor-κB ligand and osteoprotegerin in cultured equine articular cells.. Am J Vet Res (2010) 71:615–22.
    doi: 10.2460/ajvr.71.6.615pubmed: 20513175google scholar: lookup
  20. Oke SL, Hurtig MB, Keates RA. Assessment of three variations of the 1,9-dimethylmethylene blue assay for measurement of sulfated glycosaminoglycan concentration in equine synovial fluid.. Am J Vet Res (2003) 64:900–6.
    doi: 10.2460/ajvr.2003.64.900pubmed: 12856776google scholar: lookup
  21. Jouglin M, Robert C, Valette JP, Gavard F, Quintin-Colonna F, Denoix JM. Metalloproteinases and tumor necrosis factor-alpha activities in synovial fluids of horses: correlation with articular cartilage alterations.. Vet Res (2000) 31:507–15.
    doi: 10.1051/vetres:2000136pubmed: 11050746google scholar: lookup
  22. Ley C, Ekman S, Elmen A, Nilsson G, Eloranta ML. Interleukin-6 and tumor necrosis factor in synovial fluid from horses with carpal joint pathology.. J Vet Med A (2007) 54:346–51.
  23. Trumble TN, Trotter GW, Oxford JR, McIlwraith CW, Cammarata S, Goodnight JL. Synovial fluid gelatinase concentrations and matrix metalloproteinase and cytokine expression in naturally occurring joint disease in horses.. Am J Vet Res (2001) 62:1467–77.
    doi: 10.2460/ajvr.2001.62.1467pubmed: 11560279google scholar: lookup
  24. Trumble TN, Brown MP, Merritt KA, Billinghurst RC. Joint dependent concentrations of bone alkaline phosphatase in serum and synovial fluids of horses with osteochondral injury: an analytical and clinical validation.. Osteoarthritis Cartilage (2008) 16:779–86.
    doi: 10.1016/j.joca.2007.11.008pubmed: 18162418google scholar: lookup
  25. Fardellone P, Sejourne A, Paccou J, Goeb V. Bone remodeling markers in rheumatoid arthritis.. Mediators Inflamm (2014) 2014:484280.
    doi: 10.1155/2014/484280pmc: PMC4009257pubmed: 24839355google scholar: lookup
  26. Kato Y, Nakashima K, Iwamoto M, Murakami H, Hiranuma H, Koike T. Effects of interleukin-1 on synthases of alkaline phosphatase, type X collagen, and 1,25-dihydroxyvitamin D3 receptor, and matrix calcification in rabbit chondrocyte cultures.. J Clin Invest (1993) 92:2323–30.
    doi: 10.1172/JCI116836pmc: PMC288413pubmed: 8227347google scholar: lookup
  27. Nguyen L, Dewhirst FE, Hauschka PV, Stashenko P. Interleukin-1 beta stimulates bone resorption and inhibits bone formation in vivo.. Lymphokine Cytokine Res (1991) 10:15–21.
    pubmed: 1873357
  28. Stabellini G, Minola E, Dolci C, Moscheni C, Calastrini C, Lumare E. Glycosaminoglycan, collagen, and glycosidase changes in human osteoblasts treated with interleukin-1, and osteodystrophy.. Biomed Pharmacother (2007) 61:686–92.
    doi: 10.1016/j.biopha.2007.04.003pubmed: 17561366google scholar: lookup
  29. Nakase T, Takaoka K, Masuhara K, Shimizu K, Yoshikawa H, Ochi T. Interleukin-1 beta enhances and tumor necrosis factor-alpha inhibits bone morphogenetic protein-2-induced alkaline phosphatase activity in MC3T3-E1 osteoblastic cells.. Bone (1997) 21:17–21.
    doi: 10.1016/S8756-3282(97)00038-0pubmed: 9213003google scholar: lookup
  30. Sharma AR, Jagga S, Lee SS, Nam JS. Interplay between cartilage and subchondral bone contributing to pathogenesis of osteoarthritis.. Int J Mol Sci (2013) 14:19805–30.
    doi: 10.3390/ijms141019805pmc: PMC3821588pubmed: 24084727google scholar: lookup
  31. Jackson BF, Reed SR, Price JS, Verheyen KL. Relationship between serum biomarkers of cartilage and bone metabolism and joint injury in young thoroughbred racehorses in training.. Am J Vet Res (2015) 76:679–87.
    doi: 10.2460/ajvr.76.8.679pubmed: 26207965google scholar: lookup
  32. Fuller CJ, Barr AR, Sharif M, Dieppe PA. Cross-sectional comparison of synovial fluid biochemical markers in equine osteoarthritis and the correlation of these markers with articular cartilage damage.. Osteoarthritis Cartilage (2001) 9:49–55.
    doi: 10.1053/joca.2000.0349pubmed: 11178947google scholar: lookup
  33. Steinhagen J, Bruns J, Niggemeyer O, Fuerst M, Rüther W, Schünke M. Perfusion culture system: synovial fibroblasts modulate articular chondrocyte matrix synthesis in vitro.. Tissue Cell (2010) 42:151–7.
    doi: 10.1016/j.tice.2010.03.003pubmed: 20427066google scholar: lookup
  34. Lozito TP, Alexander PG, Lin H, Gottardi R, Cheng AW, Tuan RS. Three-dimensional osteochondral microtissue to model pathogenesis of osteoarthritis.. Stem Cell Res Ther (2013) 4(Suppl 1):S6.
    doi: 10.1186/scrt367pmc: PMC4029306pubmed: 24564995google scholar: lookup
  35. Peck Y, Ng LY, Goh JY, Gao C, Wang DA. A three-dimensionally engineered biomimetic cartilaginous tissue model for osteoarthritic drug evaluation.. Mol Pharm (2014) 11:1997–2008.
    doi: 10.1021/mp500026xpubmed: 24579704google scholar: lookup
  36. Richardson DW, Dodge GR. Effects of interleukin-1β and tumor necrosis factor-α on expression of matrix related genes by cultured equine articular chondrocytes.. Am J Vet Res (2000) 61:624–30.
    doi: 10.2460/ajvr.2000.61.624pubmed: 10850836google scholar: lookup
  37. Dechant JE, Baxter GM, Frisbie DD, Trotter GW, McIlwraith CW. Effects of dosage titration of methylprednisolone acetate and triamcinolone acetonide on interleukin-1-conditioned equine articular cartilage explants in vitro.. Equine Vet J (2003) 35:444–50.
    doi: 10.2746/042516403775600479pubmed: 12875321google scholar: lookup
  38. Byron CR, Stewart MC, Stewart AA, Pondenis HC. Effects of clinically relevant concentrations of glucosamine on equine chondrocytes and synoviocytes in vitro.. Am J Vet Res (2008) 69:1129–34.
    doi: 10.2460/ajvr.69.9.1129pubmed: 18764682google scholar: lookup

Citations

This article has been cited 7 times.